BKT170

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameBKT170
Drug Alias NameBKT170BKT-170
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonists
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsSkin Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiokine Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiokine Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsSkin Diseases

Other Information

ATC CodeN/A
Related LinksN/A